Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.07% | 51.42% | 57.32% | 10.91% | 12.91% |
| Total Depreciation and Amortization | 5.07% | -1.64% | -2.20% | -1.90% | -1.01% |
| Total Amortization of Deferred Charges | -7.57% | -7.96% | -62.40% | -66.34% | -69.22% |
| Total Other Non-Cash Items | 26.17% | -16.97% | -43.65% | 77.09% | 96.90% |
| Change in Net Operating Assets | 1,354.16% | 294.92% | 329.28% | -217.24% | -120.90% |
| Cash from Operations | 58.40% | 34.71% | 21.47% | 7.07% | 0.20% |
| Capital Expenditure | 73.11% | 4.15% | 12.90% | -302.52% | -269.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | 10.54% | 10.54% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.27% | -11.37% | 15.18% | -81.47% | -263.12% |
| Cash from Investing | 41.25% | 69.69% | 75.83% | -15.94% | -45.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.33% | 0.00% | 92.78% | 92.67% | 92.55% |
| Issuance of Common Stock | 56.98% | 209.20% | 987.50% | 778.84% | 28.61% |
| Repurchase of Common Stock | -20.30% | 90.91% | 95.44% | 96.21% | 97.52% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.71% | 85.80% | 93.99% | 93.15% | 89.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.90% | 313.53% | 231,164.65% | 250.29% | 109.72% |